To analyze the disparities in treatment between the protected and unprotected groups, we need to examine differences in process variants, their frequencies, and performance times. Here are the key findings:

### Main Differences:
1. **Frequency of Thorough Examination with Successful Treatment**:
   - **Unprotected Group**: There are many instances where thorough examinations are followed by successful treatment (e.g., "Register at FD -> Expert Examination -> Thorough Examination -> Diagnosis -> Treatment -> Treatment successful -> Discharge" with a high frequency of 1466).
   - **Protected Group**: These thorough examinations leading directly to successful treatment are less frequent (e.g., "Register at FD -> Expert Examination -> Thorough Examination -> Diagnosis -> Treatment -> Treatment successful -> Discharge" with a frequency of 73).

2. **Frequency of Treatment without Subsequent Diagnosis**:
   - **Unprotected Group**: Experiences more direct "Diagnosis -> Treatment -> Treatment successful -> Discharge" (e.g., frequency of 82).
   - **Protected Group**: This sequence is less common, and there's a presence of exams preceding treatment more frequently, which suggests less streamlined processes.

3. **Instances of Unsuccessful Treatment and Subsequent Retreatments**:
   - **Unprotected Group**: Shows higher occurrences where treatments are initially unsuccessful, followed by retries (e.g., multiple sequences involving "Treatment unsuccessful -> Diagnosis -> Treatment -> Treatment successful").
   - **Protected Group**: Less frequent and less complex retry sequences, indicating potential disparities in handling complications or nuances in care management.

4. **Performance and Execution Times**:
   - **Unprotected Group**: The performance times for many processes, especially those leading to treatment success, are comparable to or slightly faster than the protected group, indicating more efficient processing. Examples include sequences with frequent high performances of over 300,000 units.
   - **Protected Group**: There are broader ranges in performance times, with some considerably longer duration processes, signifying potential delays and inefficiencies.

5. **Non-treatment Discharges**:
   - **Unprotected Group**: There are instances where patients are discharged without treatment (frequency of Discharge = 505).
   - **Protected Group**: The presence of non-treatment related discharges is not significantly noted, suggesting differing protocols or documentation practices.

### Potential Indicators of Unfair Treatment:
- **Variability in Examinations and Thoroughness**: The protected group seems to have fewer resources or a less systematic approach toward handling cases that require thorough examination and successful treatment resolutions.
- **Timeliness and Performance**: There are evident disparities in the efficiency and length of certain care pathways, which could contribute to inequitable experiences and outcomes for the protected group.
- **Management of Unsuccessful Treatments**: The unprotected group is receiving more comprehensive management for unsuccessful treatments, which could indicate better follow-up protocols or access to greater resources for corrective actions.

### Conclusion:
The protected group appears to endure longer and potentially less efficient treatment processes. This might suggest inequities in resource allocation or administrative processes tailored to meet their needs. It is critical to delve deeper into the reasons behind these disparities and implement steps towards equitable health care delivery for all groups.